Abstract-Pediatric sleep apnea-hypopnea syndrome (SAHS) is a highly prevalent respiratory disorder that may impose many negative effects on the health and development of children. Due to the drawbacks of overnight polysomnography (PSG), the gold standard diagnosis technique, automated analysis of nocturnal oximetry has emerged as a simplified alternative. In order to improve diagnosis ability of oximetry, we propose to evaluate the usefulness of AdaBoost, a classification boosting algorithm, in the context of pediatric SAHS. A database composed of 981 SpO2 recordings from pediatric subjects was used. For this purpose, a signal processing approach divided into two main stages was conducted: (i) feature extraction, where 3% oxygen desaturation index (ODI3), spectral, and nonlinear features were computed from the oximetry signal, and (ii) AdaBoost classification, where an AdaBoost.M2 model was trained with these features in order to determine the severity of pediatric SAHS according to the apnea-hypopnea index (AHI): AHI<1 events per hour (e/h), 1≤AHI<5 e/h, and AHI≥5 e/h. Our AdaBoost.M2 model achieved a Cohen's kappa of 0.474 in an independent test set in the 3-class classification task. In addition, high accuracies were obtained when using the AHI cutoffs for diagnosis of mild (AHI=1 e/h) and moderate-toThis work was supported 'Ministerio de Economía y Competitividad (MINECO)' and 'European Regional Development Fund' under projects DPI2017-84280-R, TEC2014-53196-R and RTC-2015-3446-1, by 'Consejería de Educación de la Junta de Castilla y León and FEDER' under project VA037U16, by ' European Commission ' and ' European Regional Development Fund ' under project 'POCTEP 0378_AD_EEGWA_2_P', and the project 66/2016 de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
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I. INTRODUCTION
Pediatric sleep apnea-hypopnea syndrome (SAHS) is a sleep-related breathing disorder characterized by recurrent events of complete cessation (apnea) and/or significant reduction (hypopnea) of airflow during sleep [1] . Pediatric SAHS is highly prevalent (from 1 to 5%) while being underdiagnosed. This disease may cause major consequences in children's health and development, such as cardiometabolic dysfunction, neurocognitive deficits, and growth impairment [1] .
The gold standard test for pediatric SAHS diagnosis is overnight polysomnography (PSG). This nocturnal test records multiple physiological signals from pediatric patients in a specialized sleep laboratory while sleeping [1] . However, PSG is costly, complex, and highly intrusive, especially for children [2] , [3] . Furthermore, it results in long waiting lists, due to its limited availability and the high prevalence of pediatric SAHS.
Due to these limitations, the search for simplified diagnosis techniques has become a major challenge for the scientific community [2] . A common approach is the use of a reduced set of signals included in the PSG. In this sense, nocturnal oximetry has been frequently advocated as a simple and reliable test for children [2] , [4] . In addition, oximetry only requires a finger or earlobe sensor to record the blood oxygen saturation (SpO2) signal [4] , [5] .
Previous research has shown the potential usefulness of the automated analysis of nocturnal oximetry recordings to help in the screening of pediatric SAHS [5] - [9] . These studies applied different signal processing algorithms, together with different pattern recognition techniques, such as linear discriminant analysis (LDA) [5] , logistic regression (LR) [6] , [7] , and multi-layer perceptron (MLP) neural networks [8] , [9] . However, these techniques are based only on one classification model. By contrast, ensemble learning algorithms combine several classification models to outperform the results of each one separately [10] . In this sense, the adaptive boosting method (AdaBoost) is a boosting classification algorithm that has the ability to produce models with high performance when they are validated in a new set of data [10] . In addition, AdaBoost has been successfully applied to improve the diagnostic ability of the airflow signal in SAHS screening in adult patients [11] .
Based on the aforementioned considerations, we hypothesize that AdaBoost could enhance the diagnosis ability of the oximetry signal in the context of pediatric SAHS. Thus, our objective is to evaluate the usefulness of AdaBoost to assist in the screening of pediatric SAHS using the oximetry signal. To achieve this objective, a two stepsmethodology was conducted: feature extraction and AdaBoost classification. In the feature extraction stage, 3% oxygen desaturation index (ODI3), spectral features from power spectral density (PSD), and nonlinear features were obtained from the SpO2 signal. ODI3 is a conventional oximetric index commonly employed to quantify the number of SpO2 desaturations. Spectral analysis is related to the duration and recurrence of respiratory events, whereas nonlinear analysis provides information about nonstationary properties of the SpO2 signal associated to apneic events. These signal processing approaches have proven its usefulness to characterize the oximetry signal in pediatric SAHS screening [5] - [9] . In the second phase, an AdaBoost classifier was fed with these features (ODI3, spectral and nonlinear features) in order to determine the severity of SAHS according to the apnea-hypopnea index (AHI) from nocturnal PSG.
II. SUBJECTS AND SIGNALS UNDER STUDY
The dataset analyzed in this study was composed of 981 children (602 boys and 379 girls) ranging from 2 to 13 years of age. All children were referred to the Pediatric Sleep Unit at the University of Chicago Medicine Comer Children's Hospital (Chicago, IL, USA) due to clinical suspicion of SAHS. An informed consent was obtained for each patient in order to be included in this study. In addition, the Ethical Committee approved the protocol.
Children's sleep was monitored using a digital polysomnography system (Polysmith; Nihon Kohden America Inc., CA, USA). SpO2 recordings were acquired at sampling rates of 25, 200, and 500 Hz. SpO2 recordings were subsequently resampled to a common sample rate of 25 Hz, as recommended by the American Academy of Sleep Medicine (AASM), and were also rounded to the second decimal place [9] . Artifacts due to patient's movements were automatically discarded from each recording by removing sudden changes between consecutive SpO2 sampling intervals ≥4%/s and SpO2 values below 50% [8] . Sleep and apneic events were quantified and the AHI, which is the number of apnea and hypopnea events per hour (e/h) of sleep, was estimated using the rules of the AASM [12] . According to previous studies, children showing an AHI<1 e/h were classified as no-SAHS, those with 1≤AHI<5 e/h were classified as mild SAHS, and children showing an AHI≥5 e/h were classified as moderate-to-severe SAHS [13] , [14] .
The dataset was randomly divided into two sets: training set (60%), used to optimize the feature extraction stage as well as train the AdaBoost model, and test set (40%), used to assess the diagnostic performance of the AdaBoost model in an independent dataset. Table I shows clinical and demographic data of the population under study.
III. METHODOLOGY
Our proposal was developed in two stages. First, ODI3, spectral and nonlinear features were computed from each oximetry recording. Then, an AdaBoost classifier was trained using these features to estimate the severity of SAHS.
A. Feature Extraction
The following features subsets were composed to obtain an initial set of 10 features:
 Oxygen desaturation index. ODI3 was computed in order to obtain information about the number of SpO2 desaturation events [15] . It is defined as the number of desaturations greater than or equal 3% per hour of recording [15] .
 Spectral features. Spectral analysis was applied to explore differences in the spectral information associated to the duration and periodicity of SAHS events [6] . PSD was estimated using the Welch's method (2 13 -sample Hamming window, 50% overlap and 2 14 -points DFT). A band of interest was determined as the region of the PSD with more statistical differences in the PSD amplitude between the three severity groups: 0.020-0.044 Hz. Then, the following features were obtained from the PSD in this band: first-to-fourth statistical moments (M1f-M4f), maximum (MA) and minimum amplitude (mA).
 Nonlinear parameters. Nonlinear analysis has proven to be useful to extract additional information of oximetry dinamics [6] . In this sense, central tendency measure (CTM), Lempel-Ziv complexity (LZC) and sample entropy (SampEn) were computed to measure the variability, complexity and irregularity of the SpO2 signal, respectively.
B. AdaBoost Classification: AdaBoost.M2
Boosting algorithms employ models of the same type that complement one another. These models are obtained in an iterative way and their individual outputs are combined using a weighted vote scheme [10] . AdaBoost is a widely used boosting method that can be employed with any classifier. However, its prediction ability on a new set of data decreases if it is employed with complex classifiers [10] . Thus, it is preferable to use AdaBoost with a simple classification algorithm as weak learner [10] . In this study, the well-known LDA algorithm has been chosen as weak learner, which has previously shown its usefulness in the context of adult SAHS [11] . Since our problem is a 3-class classification task (AHI<1 e/h, 1≤AHI<5 e/h, and AHI≥5 e/h), the AdaBoost.M2 version of the algorithm has been used [10] .
AdaBoost.M2 assigns a weight wj k to every instance xj in the training set (j=1,2, …, M, being M the number of instances) at each k iteration. The k-th weak classifier is then trained using the weighted instances. Then, the error ϵk of the classifier is calculated using a weighted pseudo-loss [16] :
where c is the number of classes, ctrue is the class of the instance xj, and hk is the confidence of the prediction of the weak classifier for an instance xj and a class from c.
This error ϵk is used to obtain the weighted vote αk for this k-th classifier [16] :
Classifiers with smaller error ϵk have a higher weight αk, thus having more importance on the final model. At the end of each iteration, the weights of the training instances are updated, assigning a higher weight wj k+1 to those instances j that have not been rightly classified [10] . These weights are normalized so that their sum remains the same as in the previous iteration. Thus, the classifier focuses more on instances with a high weight in the next iteration in order to not misclassify them again [10] .
At the end of the iterative process, the algorithm AdaBoost.M2 performs the final classification task for each instance xj. It obtains, for each xj, the class where the sum of the votes of all the classifiers is maximum, taking into account their weighted votes αk [10] .
C. Statistical Analysis
The Kruskal-Wallis test was used to search for significant statistical differences (p-value <0.01) among SAHS severity groups (AHI<1 e/h, 1≤AHI<5 e/h, and AHI≥5 e/h). Diagnostic ability of the AdaBoost classifier was assessed by means of sensitivity (Se, percentage of SAHS positive patients rightly classified), specificity (Sp, percentage of SAHS negative children rightly classified), accuracy (Acc, percentage of subjects rightly classified), and Cohen's kappa index (kappa). SMOTE was applied to the no-SAHS group (98 subjects) in the training set in order to compensate for imbalance with respect to the mild SAHS group (232 subjects), and moderate-to-severe SAHS (259 subjects) when training the AdaBoost.M2 classifier. Therefore, synthetic samples were obtained for each feature to reach 196 no-SAHS subjects.
IV. RESULTS

A. Training Set
The proposed 10 features were computed in the training group to conform the initial feature set. All features except M3f and M4f reached significant statistical differences (pvalue <0.01) between SAHS severity groups. Then, the 687 samples (589 originals and 98 synthetic) of the training set, each one composed of these features, fed the AdaBoost.M2 algorithm. AdaBoost.M2 was trained in a 100 steps iteration procedure, in order to minimize the overfitting chances.
B. Test Set
The AdaBoost.M2 model obtained was further validated in the independent test set. Table II shows the confusion matrices for this AdaBoost.M2 model, as well as the conventional oximetric index ODI3. These models rightly classified 66.3% (AdaBoostM2) and 62.5% (ODI3) of the subjects in the test set, whereas the 3-class kappa were 0.474 (AdaBoostM2) and 0.410 (ODI3), respectively. Table III shows the diagnostic performance parameters derived from the confusion matrices when assessing individual AHI cutoffs values of 1 and 5 e/h. Notice that the results obtained with AdaBoost.M2 slightly improved the performance of ODI3 in terms of Acc for both AHI cutoffs: 80.9% vs. 79.1% (AHI≥1 e/h) and 82.9% vs. 81.6% (AHI≥5 e/h).
V. DISCUSSION
In this study, the utility of an AdaBoost.M2 model was assessed to determine the severity of pediatric SAHS using the oximetry signal. This model was fed with ODI3, spectral, and nonlinear features. It outperformed ODI3 in the 3-class (no SAHS, mild SAHS, and moderate-to-severe SAHS) classification task in terms of overall Acc (66.3% vs. 62.5%), as well as kappa (0.474 vs. 0.410). Furthermore, AdaBoost.M2 reached higher Acc than ODI3 alone when assessing the AHI thresholds of 1 e/h (80.9% vs. 79.1%) and 5 e/h (82.9% vs. 81.6%). Nevertheless, ODI3 achieved a slightly higher Se for both cutoffs (1 e/h and 5 e/h). These cutoffs were not arbitrary selected. They define the presence of SAHS (mild SAHS, AHI≥1 (e/h)) and the need for surgical treatment (moderate-to-severe SAHS, AHI≥5 (e/h)) [13] , [14] . In this regard, and according to the confusion matrices, 98.3% (115/117) of subjects predicted as moderate-to-severe SAHS (AHI≥5 e/h) by the AdaBoost.M2 model are at least mild patients (AHI≥1 e/h). Furthermore, 91.1% (82/90) of subjects predicted as no-SAHS (AHI<1 e/h) do not suffer from SAHS or are mild SAHS.
Previous studies also assessed the usefulness of the automated analysis of the oximetry signal in the screening of pediatric SAHS [5] - [9] . Garde et al. [5] assessed a LDA model trained with PSD and time domain features from a database of 146 SpO2 and PR recordings, achieving 88.4% Se and 83.6% Sp (AHI≥5 e/h). Álvarez et al. [6] evaluated binary LR models trained with automatic features from 50 SpO2 recordings for different AHI cutoffs (1, 3, and 5 e/h), reaching 85.5% Acc for AHI≥1 e/h, 83.4% Acc for AHI≥3 e/h, and 82.8% Acc for AHI≥5 e/h. Crespo et al. [7] employed a LR model fed with features from multiscales entropy and conventional oximetric indices computed from the SpO2 signal. This model achieved 83.5% Acc (AHI≥3 e/h) in a database of 50 recordings. Nonetheless, these studies [5] - [7] only aimed at the detection of pediatric SAHS, thus only focused on binary classification. In addition, these studies used smaller databases than in our proposal [5] - [7] .
In contrast to these studies [5] - [7] , Vaquerizo-Villar et al. [8] and Hornero et al [9] developed MLP models in order to determine pediatric SAHS severity. Vaquerizo-Villar et al [8] assessed a classification MLP model fed with ODI3, PSD, bispectral, and anthropometric variables using a database of 298 SpO2 recordings, reaching 81.3% and 85.3% Acc in the detection of moderate-to-severe (AHI ≥5 e/h) and severe (AHI ≥10 e/h) SAHS, respectively. Hornero et al [9] , in a multicenter international study, developed a regression MLP model built with automated features computed from 4191 SpO2 recordings from 13 sleep laboratories, reaching 75.2%, 81.7%, and 90.2% Acc for common AHI severity cutoffs of 1 e/h, 5 e/h, and 10 e/h, respectively. However, our proposal outperformed the results obtained in these studies for the detection of mild and moderate-to-severe SAHS, especially in the former case (AHI ≥1 e/h).
Despite our proposal reached promising results, there exist some limitations that must be taken into account. First, in spite of the number of subjects is high, more subjects with an AHI<1 e/h would be necessary to improve the AdaBoost.M2 model training. Additionally, further validation of our proposal would be required in order to assess the effects of regularization and different number of LDA classifiers for the AdaBoost.M2 algorithm as well as to compare the Adaboost.M2 model with the performance of other classification algorithms. Finally, it would also be appropriate to validate this methodology in unsupervised oximetry recordings obtained at patient's home.
VI. CONCLUSIONS
In summary, a multiclass Adaboost.M2 model fed with automated parameters computed from the oximetry signal achieved high performance in an independent test set in order to assess pediatric SAHS severity. Furthermore, this model achieved slightly higher diagnostic accuracies than the classical clinical index ODI3, as well as other state-ofthe-art studies, in the detection of mild and moderate-tosevere SAHS. Therefore, we can conclude that Adaboost could help to improve the diagnostic ability of the oximetry signal in the context of pediatric SAHS. 
